journal article·2025-06Open access

pH-driven butterfly effect for cascade-amplified tumor therapy based on thalidomide coordinated Fe-HMME nanoplatform

Botao Qu, Qian Wang, Yuxin Zhou, Xiaogang Ning, Qian Wang, Ziyi Zhou, Peirong Bai, Ruiping Zhang

Abstract

A promising approach for treating intractable cancers has been presented by photodynamic therapy (PDT). However, the limited penetration depth of PDT and suboptimal monotherapy efficacy of PDT significantly restrict its clinical applications. In this study, we constructed an acidic tumor microenvironment (TME)-activated carrier-free nanoplatform (HMME-Fe-Thal, abbreviated as HFT) through self-assembly of iron ions, photosensitizer hematoporphyrinmonomethyl ether (HMME) and anti-angiogenesis drug thalidomide (Thal). Near infrared (NIR) triggers PDT behavior before the degradation of the HFT nanoplatform. Subsequently, the HFT nanoplatform degrades, releasing Thal for chemotherapy, iron ions for chemodynamic therapy (CDT), which reinforce the therapeutic benefits of PDT synergistically. Moreover, the iron ions released by HFT degradation turn on the MRI signal, which can suggest the most appropriate time for PDT, divide the treatment into two stages (First-stage: PDT, Second-stage: CDT/chemotherapy), and gradually achieve cascade-amplified tumor therapy. In this sense, HFT modulates TME and leads to a "butterfly effect" of CDT/chemotherapy/glutathione (GSH) depletion for enhanced PDT efficacy. This strategy compensates the deficient shadow penetration and poor treatment efficacy from PDT monotherapy. This work presents the selection and rational design of HFT constructed by endogenous components for tumor regression, and greatly push nanomaterials towards the development of PDT application.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. Dye sensitizers for photodynamic therapy10.3390/ma6030817 ↗
2. Oncologic photodynamic therapy: basic principles, current clinical status and future directions10.3390/cancers9020019 ↗
3. Forging forward in photodynamic therapy10.1158/0008-5472.CAN-21-4122 ↗
4. Nanoparticles in photodynamic therapy10.1021/cr5004198 ↗
5. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
6. Clinical development of metal complexes as photosensitizers for photodynamic therapy of cancer10.1002/anie.202112236 ↗
7. Chemistry and biology of reactive oxygen species in signaling or stress responses10.1038/nchembio.607 ↗
8. Intracellular signaling mechanisms in photodynamic therapy
9. Activatable singlet oxygen generation from lipid hydroperoxide nanoparticles for cancer therapy10.1002/anie.201701181 ↗
10. Chem. Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies10.1039/D0CS01370F ↗
11. Photodynamic therapy-current limitations and novel approaches10.3389/fchem.2021.691697 ↗
12. Photodynamic therapy-current limitations and novel approaches
13. Tumor-microenvironment-responsive poly-prodrug encapsulated semiconducting polymer nanosystem for phototherapy-boosted chemotherapy10.1039/D3MH00242J ↗
14. Piezopotential-driven simulated electrocatalytic nanosystem of ultrasmall MoC quantum dots encapsulated in ultrathin N-doped graphene vesicles for superhigh H2 production from pure water
15. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy10.1016/j.molcel.2020.05.034 ↗
16. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nature reviews10.1038/s41577-020-0406-2 ↗
17. Coordination polymer-coated CaCO3 reinforces radiotherapy by reprogramming the immunosuppressive metabolic microenvironment10.1002/adma.202106520 ↗
18. Chem. New opportunities for immunomodulation of the tumour microenvironment using chemical tools10.1039/D2CS00486K ↗
19. Endogenous tumor microenvironment-responsive multifunctional nanoplatforms for precision cancer theranostics10.1016/j.ccr.2020.213529 ↗
20. Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics10.1016/j.nantod.2020.100851 ↗
21. Tumor microenvironment stimuli-responsive fluorescence imaging and synergistic cancer therapy by carbon-dot-Cu(2+) nanoassemblies10.1002/anie.202007786 ↗
22. A simple glutathione-responsive turn-on theranostic nanoparticle for dual-modal imaging and chemo-photothermal combination therapy10.1021/acs.nanolett.9b02769 ↗
23. Specific “Unlocking”of a nanozyme-based butterfly effect to break the evolutionary fitness of chaotic tumors10.1002/anie.201916142 ↗
24. Cascade catalytic nanoplatform based on "butterfly effect" for enhanced immunotherapy10.1002/adhm.202002171 ↗
25. Nanoreactor of“butterfly effect” inciting a triple interlocked combination of starvation/chemo/metal ion therapy by remodeling tumor microenvironment10.1016/j.cej.2020.126571 ↗
26. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles10.1021/ar200022e ↗
27. Tumor microenvironment activated chemodynamic–photodynamic therapy by multistage self ‐ assembly engineered protein nanomedicine10.1002/adfm.202112251 ↗
28. Tumor-microenvironment-responsive biodegradable nanoagents based on lanthanide nucleotide self-assemblies toward precise cancer therapy10.1002/anie.202116983 ↗
29. Metal-coordinated supramolecular self-assemblies for cancer theranostics10.1002/advs.202101101 ↗
30. A metal-polyphenol-coordinated nanomedicine for synergistic cascade cancer chemotherapy and chemodynamic therapy10.1002/adma.201906024 ↗
31. Amino acid coordination driven self‐assembly for enhancing both the biological stability and tumor accumulation of curcumin10.1002/anie.201810087 ↗
32. Self-assembled minimalist multifunctional theranostic nanoplatform for magnetic resonance imaging-guided tumor photodynamic therapy10.1021/acsnano.8b03529 ↗
33. Tumor microenvironment-responsive ultrasmall nanodrug generators with enhanced tumor delivery and penetration10.1021/jacs.8b09396 ↗
34. Molecular mechanisms of iron and heme metabolism10.1146/annurev-nutr-062320-112625 ↗
35. Ferroptosis-driven nanotherapeutics for cancer treatment10.1016/j.jconrel.2020.01.008 ↗
36. NIR-II excitation phototheranostic platform for synergistic photothermal therapy/chemotherapy/chemodynamic therapy of breast cancer bone metastases10.1002/advs.202204718 ↗
37. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications10.1038/sj.leu.2402295 ↗
38. Coordination bonding based pH-responsive drug delivery systems10.1016/j.ccr.2013.03.007 ↗
39. Smart J-aggregate of cyanine photosensitizer with the ability to target tumor and enhance photodynamic therapy efficacy10.1016/j.biomaterials.2020.120532 ↗
40. Anionic cyanine J-type aggregate nanoparticles with enhanced photosensitization for mitochondria-targeting tumor phototherapy10.1002/anie.202203093 ↗
41. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the fas pathway of apoptosis10.1016/S0092-8674(00)81590-1 ↗
42. High-performance self-cascade pyrite nanozymes for apoptosis-ferroptosis synergistic tumor therapy10.1021/acsnano.1c01248 ↗
43. Ultrasound-augmented nanocatalytic ferroptosis reverses chemotherapeutic resistance and induces synergistic tumor nanotherapy10.1002/adfm.202107529 ↗
44. Biodegradable ferric phosphate nanocarriers with tumor-specific activation and glutathione depletion for tumor self-enhanced ferroptosis and chemotherapy10.1002/adfm.202313540 ↗
45. Precise design of TiO2@CoOx heterostructure via atomic layer deposition for synergistic sono-chemodynamic oncotherapy10.1002/advs.202304046 ↗
46. A multifunctional bimetallic nanoplatform for synergic local hyperthermia and chemotherapy targeting HER2-positive breast cancer10.1002/advs.202308316 ↗
47. Tumor microenvironment-activatable nanosystem capable of overcoming multiple therapeutic obstacles for augmenting immuno/metal-ion therapy10.1021/acsnano.3c12745 ↗
48. Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy10.1038/s41467-022-31044-6 ↗